Publications by authors named "S Z Badawy"

Hospitalized patients with sickle cell disease (SCD) may use opioid medications for both acute and chronic pain management. Use of these medications may unintentionally generate diagnostic codes for opioid misuse including "opioid use," "opioid abuse," and "opioid dependence," which connote a behavioral problem or addiction. In this study, we sought to compare diagnostic codes for opioid misuse amongst hospitalized patients with and without SCD.

View Article and Find Full Text PDF

This study presents a significant advancement in tandem dye-sensitized solar cells (T-DSSCs) through the strategic synthesis of novel triazatruxene (TAT) sensitizers MS-1 and MS-2. These organic sensitizers demonstrate exceptional light-harvesting capacity and overall performance, pushing the boundaries of power conversion efficiency (PCE) in DSSCs. The MS-1-based DSSCs achieved an impressive PCE of 12.

View Article and Find Full Text PDF

Painimation, a novel digital pain assessment tool, allows patients to communicate their pain quality, intensity, and location using abstract animations (painimations) and a paintable body image. This study determined the construct validity of painimations and body image measures by testing correlations with validated pain outcomes in adults with sickle cell disease (SCD). Analyses used baseline data from a multisite randomized trial of 359 adults with SCD and chronic pain.

View Article and Find Full Text PDF
Article Synopsis
  • A study looked at how to manage chronic pain in adults with sickle cell disease (SCD) using digital programs for therapy and education.
  • It involved 359 adults who were split into two groups: one received cognitive-behavioral therapy (CBT) using an app, while the other got education about pain management.
  • After 6 months, both groups showed similar results in reducing pain interference, and there were no big differences in their daily pain levels, depression, anxiety, or quality of life.
View Article and Find Full Text PDF
Article Synopsis
  • Oral lichen planus and oral lichenoid lesions are chronic inflammatory conditions considered potentially malignant disorders, and their immune profiles were compared in this study.
  • The research involved four study groups (dysplastic and non-dysplastic cases of both conditions), examining the immune expression of β-catenin and CD163 through immunohistochemistry.
  • Results indicated a significant difference between groups and a moderate positive correlation between β-catenin and CD163, suggesting a link that could inform new treatment strategies for these oral conditions.
View Article and Find Full Text PDF